Viewing Study NCT05241834


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2025-12-27 @ 11:05 PM
Study NCT ID: NCT05241834
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-04
First Post: 2022-02-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module